The polycomb group protein BMI-1 inhibitor PTC-209 is a potent anti-myeloma agent alone or in combination with epigenetic inhibitors targeting EZH2 and the BET bromodomains
| Image |  |
|---|---|
| Description | scientific article published on 20 October 2017 |
| Author/s |
author: Hareth Nahi Mohammad Alzrigat Muntasir Mamun Majumder |
| Publication date | October 20, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |